Sign in to view content

Patients Ultra-Responsive to Ranibizumab (RBZ): Rates of >4-Step Improvement in Diabetic Retinopathy Severity in DRCR.net Protocol S

Allen Chiang, MD, FASRS

Video
Published 2019

Related

Elamipretide, a Mitochondria-Targeted Drug for the Treatment of Vision Loss
Scott W. Cousins, MD
Updates from the Field
2019
Geographic Trends in the Recruitment of Participants of Racial and Ethnic Minorities for Diabetic Retinopathy-Related Clinical Trials
Vivienne S. Hau, MD, PhD
Annual Meeting Talks
2023
Response to Ranibizumab of Eyes With Pigment Epithelial Detachments, Including Eyes That Developed RPE Tears: Data From the HARBOR Study
David A. Eichenbaum, MD, FASRS
Annual Meeting Talks
2016

Category: Diabetic Retinopathy

See more